Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

9
Number of overlapping holdings
30.0%
% of PJP's 30 holdings also in PPH
37.5%
% of PPH's 27 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PJP |
Weight in PPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 5.4% | 12.4% | 5.4% | |
ABBVIE INC | 5.0% | 5.9% | 5.0% | |
MERCK & CO. INC. | 5.2% | 5.0% | 5.0% | |
BRISTOL-MYERS SQUIBB CO | 4.9% | 5.7% | 4.9% | |
JOHNSON & JOHNSON | 4.8% | 6.4% | 4.8% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to PPH
ABBOTT LABORATORIES | 4.9% | |
AMGEN INC | 4.7% | |
TARSUS PHARMACEUTICALS, INC. | 3.1% | |
GILEAD SCIENCES INC | 2.8% | |
SUPERNUS PHARMACEUTICALS INC | 2.8% | |
UNITED THERAPEUTICS CORP | 2.8% | |
COLLEGIUM PHARMACEUTICAL, INC. | 2.7% | |
REGENERON PHARMACEUTICALS | 2.7% | |
PRESTIGE BRANDS HOLDINGS INC | 2.7% | |
LIQUIDIA TECHNOLOGIES, INC. | 2.7% |
PJP Underweight Relative to PPH
NOVO-NORDISK A/S-SPONS ADR | -8.1% | |
ELI LILLY & CO | -7.0% | |
MCKESSON CORP | -5.6% | |
AMERISOURCEBERGEN CORP | -4.9% | |
NOVARTIS AG-ADR | -4.7% | |
ZOETIS INC | -4.7% | |
ASTRAZENECA PLC-SPONS ADR | -4.6% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.5% | |
SANOFI-AVENTIS-ADR | -4.0% | |
GLAXOSMITHKLINE PLC-SPON ADR | -3.9% |